FDA Approves Dysport for Use Against Wrinkles
There is a new wrinkle fighter in town. The FDA has approved Medicis’ botulium toxin drug, Dysport. They plan to release the drug for public use within the next two months. This marks the first time that Botox giant Allergan will have competition in the wrinkle, anti-aging market in the U.S. More news to follow.
 |
|
 |
Recent Posts
- Let’s Get Naked…The Fat Freezing Machine’s Commercial Not Seen During the Superbowl
- Fraxel Dual and Fraxel Clear + Brilliant Featured in VOGUE Magazine Available at Persky Sunder Plastic Surgery
- Ultherapy (Ulthera) 2012 Update: “Doc, Will Ultherapy Work, or Do I Need a Facelift?”
- “Bro-Tox”, Botox for Men
- Tell Me Santa, What is it That Bothers You About Your Appearance?
gfhgf
Comments:
Comments
Leave a reply